Middle East & Africa Colorectal Cancer Diagnostics Market Forecast to 2028

Middle East & Africa Colorectal Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others) and Stool-Based Tests (Faecal Immunochemical Test (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institute, and Others)

Send Enquiry
Item ID: BMIRE00028833 Category: Tags: , ,

$2,100$3,500

Description

The Middle East & Africa colorectal cancer diagnostics market was valued at US$ 535.53 million in 2023 and is expected to reach US$ 724.56 million by 2028. It is estimated to register a CAGR of 6.2% from 2023 to 2028.

Use of Artificial Intelligence in Colonoscopy to Drive Middle East & Africa Colorectal Cancer Diagnostics Market in Coming Years

The early detection of colorectal cancer (CRC) in gastroenterology offers patients the best opportunity for disease-free and overall survival. However, colonoscopy results show significant variations in lesion detection. The adenoma detection rate (ADR) is the gold standard for evaluating the quality of colonoscopy performed by endoscopists for colorectal cancer screening.

The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to “see” and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize “normal” characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.

Although AI in colonoscopy is a new field with an extended scope, it can potentially improve the quality of endoscopic examinations and patient care. It can also transform the process of managing performance and quality betterment in colonoscopy, alongside improving several key performance measures. Medtronic has launched its AI-powered GI Genius module for colonoscopy in India. This transformative solution that leans on deep learning algorithms and real-time data empowers physicians to detect and treat colorectal cancer by offering enhanced visualization during colonoscopy. AI applications such as the GI Genius can lead to an improved ADR, facilitating the earlier detection of colorectal cancer, better clinical management of lesions, and detailed characterization of tissues. Thus, the adoption of AI for colorectal cancer imaging tests is likely to bring new trends in the Middle East & Africa colorectal cancer diagnostics market in the coming years.

Middle East & Africa Colorectal Cancer Diagnostics Market Overview

The Middle East & Africa colorectal cancer diagnostics market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. According to the Journal of HealthCare Sciences (JOHS), colorectal cancer is the second most common cancer in Saudi Arabia, with estimated prevalence rates of 9.9% and 6.4% in males and females, respectively. Notably, most reported CRC cases in Saudi Arabia are diagnosed during clinical investigations rather than screening programs. Colorectal cancer occurs at a younger age in Saudis, particularly in women, which has significant implications for decisions about the threshold age for screening. According to Frontiers Oncology, in 2021, over 85% of the Saudi population was less than 50 years old, with a rising risk of early-onset colorectal cancer. In Saudi Arabia, there is no early screening for colorectal cancer (CRC), which leads to delayed detection and increased late-stage diagnosis. Hence, low public awareness about CRC screening, low medical adherence to the recommendation for CRC screening, and the lack of a national guideline for CRC are among the major factors affecting the decisions regarding CRC screening. Further, increasing obesity rate is the primary factor for the growing cases of CRC in the country. According to a study, “Colorectal Cancer in Saudi Arabia,” published by the National Library of Medicine, the increasing incidence rate of CRC in Saudi Arabia is attributed to the increasing adoption of a sedentary lifestyle with less physical activity and high obesity rates. Therefore, owing to the abovementioned factors, the Middle East & Africa colorectal cancer diagnostics market would grow gradually in the country during the forecast period.

Middle East & Africa Colorectal Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Colorectal Cancer Diagnostics Market Segmentation

The Middle East & Africa colorectal cancer diagnostics market is segmented into modality, end user, and country.

Based on modality, the Middle East & Africa colorectal cancer diagnostics market is bifurcated into imaging tests and stool-based tests. In 2023, the imaging tests segment held a larger share of the Middle East & Africa colorectal cancer diagnostics market. The market for the imaging tests segment is further segmented into colonoscopy, CT colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gFOBT), and stool DNA test.

Based on end user, the Middle East & Africa colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2023, the hospitals segment held the largest share of the Middle East & Africa colorectal cancer diagnostics market.

Based on country, the Middle East & Africa colorectal cancer diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. In 2023, Saudi Arabia accounted for the largest share of the Middle East & Africa colorectal cancer diagnostics market.

Medtronic Plc, Illumina Inc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, and Bruker Corp. are the leading companies operating in the Middle East & Africa colorectal cancer diagnostics market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 6.2% CAGR, the Middle East & Africa Colorectal Cancer Diagnostic Market is speculated to be worth US$ 724.56 million by 2028, saysthe research team

According tothe research team’ research, the Middle East & Africa colorectal cancer diagnostic market was valued at US$ 535.53 million in 2023 and is expected to reach US$ 724.56 million by 2028, registering a CAGR of 6.2% from 2023 to 2028. Increasing prevalence of colorectal cancer and use of artificial intelligence in colonoscopy are the critical factors attributed to the Middle East & Africa colorectal cancer diagnostic market expansion.

Colorectal cancer is a malignant tumor that develops in colonic or rectal tissues. Surgery is the most common treatment for all stages of colon cancer. In ideal situations, if the cancer is diagnosed in the early stages, doctors can remove the tumor via surgical procedures. A colonoscopy is an important screening test for colorectal cancer diagnostics, and it has become a part of routine cancer screening. Thus, the rising incidence of colorectal cancer drives the growth of the Middle East & Africa colorectal cancer diagnostics market.

On the contrary, low accuracy of screening based on faecal immunochemical tests (FITs) hurdles the growth of Middle East & Africa colorectal cancer diagnostic market.

Based on modality, the Middle East & Africa colorectal cancer diagnostics market is bifurcated into imaging tests and stool based tests. The imaging tests segment held 95.9% share of Middle East & Africa colorectal cancer diagnostic market in 2023, amassing US$ 513.53 million. It is projected to garner US$ 697.21 million by 2028 to expand at 6.3% CAGR during 2023–2028. The market for the imaging tests segment is further segmented into colonoscopy, CT colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gFOBT), and stool DNA test.

Based on end user, the Middle East & Africa colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. The hospitals segment held 42.3% share of Middle East & Africa colorectal cancer diagnostic market in 2023, amassing US$ 226.52 million. It is projected to garner US$ 314.23 million by 2028 to expand at 6.8% CAGR during 2023–2028.

Based on country, the Middle East & Africa colorectal cancer diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 47.5% share of Middle East & Africa colorectal cancer diagnostic market in 2023. It was assessed at US$ 254.25 million in 2023 and is likely to hit US$ 346.23 million by 2028, exhibiting a CAGR of 6.4% during the forecast period.

Key players profiles in the Middle East & Africa colorectal cancer diagnostic market report Medtronic Plc, Illumina Inc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, and Bruker Corp., among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Colorectal Cancer Diagnostics Market – by Modality
1.3.2 Middle East & Africa Colorectal Cancer Diagnostics Market – by End User
1.3.3 Middle East & Africa Colorectal Cancer Diagnostics Market – by Country
2. Middle East & Africa Colorectal Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Colorectal Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Colorectal Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 Launches of New Products
5.2 Key Restraints
5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Future Trends
5.3.1 Artificial Intelligence in Colonoscopy
5.4 Impact Analysis
6. Colorectal Cancer Diagnostics Market – Middle East & Africa Analysis
6.1 Middle East & Africa Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis
7. Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by Modality
7.1 Overview
7.2 Middle East & Africa Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
7.3.1 Overview
7.3.2 Stool Based Tests: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Faecal Immunochemical Test (FIT)
7.3.3.1 Overview
7.3.3.2 Faecal Immunochemical Test (FIT): Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
7.3.4.1 Overview
7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool DNA Test
7.3.5.1 Overview
7.3.5.2 Stool DNA Test: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Colonoscopy
7.4.3.1 Overview
7.4.3.2 Colonoscopy: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 CT Colonography
7.4.4.1 Overview
7.4.4.2 CT Colonography: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Flexible Sigmoidoscopy
7.4.5.1 Overview
7.4.5.2 Flexible Sigmoidoscopy: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Capsule Endoscopy
7.4.6.1 Overview
7.4.6.2 Capsule Endoscopy: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by End User
8.1 Overview
8.2 Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
8.5.1 Overview
8.5.2 Cancer Research Institutes: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – Country Analysis
9.1 Overview
9.1.1.1 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 Saudi Arabia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.1.3.1 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.1.3.2 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.1.4 Saudi Arabia Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 South Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.2.3.1 South Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.2.3.2 South Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.2.4 South Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.3 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 UAE: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.3.3.1 UAE: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.3.3.2 UAE: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.3.4 UAE Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.4 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.3 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.4.3.1 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.4.3.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.4.4 Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
10. Middle East & Africa Colorectal Cancer Diagnostics Market–Industry Landscape
10.1 Overview
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Illumina Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Quest Diagnostics Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Siemens Healthineers AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bruker Corp
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Eiken Chemical Co., Ltd.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Colorectal Cancer Diagnostics Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 3. Saudi Arabia Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. Saudi Arabia Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. South Africa Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. South Africa Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. UAE Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 11. UAE Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 12. UAE Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 13. UAE Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Middle East & Africa colorectal cancer diagnostics market
Table 19. Recent Organic Growth Strategies in the Middle East & Africa colorectal cancer diagnostics market
Table 20. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Colorectal Cancer Diagnostics Market Segmentation
Figure 2. Middle East & Africa Colorectal Cancer Diagnostics Market, by Country
Figure 3. Middle East & Africa Colorectal Cancer Diagnostics Market Overview
Figure 4. Imaging Tests Segment Held Largest Share of Modality Segment in Middle East & Africa Colorectal Cancer Diagnostics Market
Figure 5. South Africa Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Middle East & Africa Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 11. Stool Based Tests: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Faecal Immunochemical Test (FIT): Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Guaiac-based Faecal Occult Blood Test (gFOBT): Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Stool DNA Test: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Imaging Tests: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Colonoscopy: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. CT Colonography: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Flexible Sigmoidoscopy: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Capsule Endoscopy: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
Figure 22. Hospitals: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Diagnostic Laboratories: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cancer Research Institutes: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Middle East & Africa: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 27. Middle East & Africa: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 28. Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – Middle East & Africa Colorectal Cancer Diagnostics Market
– Bruker Corp
– F. Hoffmann-La Roche Ltd
– Illumina Inc
– Medtronic Plc
– Quest Diagnostics Inc
– Siemens Healthineers AG

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Colorectal Cancer Diagnostics Market Forecast to 2028”